Relation Between Anthropometric Measurements and Balance in Children With Type 1 Diabetes Relation Between Anthropometric Measurements and Balance in Children With Type 1 Diabetes

January 30, 2024 updated by: Amira Mahmoud Abd-elmonem, Cairo University

Relation Between Anthropometric Measurements and Balance in Children With Type 1 Diabetes

Type 1 diabetes mellitus is the most common chronic metabolic disorder in children. Diabetic children who take proper nutrition and good care attain normal growth status. Factors affecting growth in diabetic patients include gender, age at diagnosis, duration of disease, glycemic control, and puberty status. Moreover, diabetes mellitus has negative impact on vestibular system, affect proprioception and lower limb muscle fatigue resulting in reduced balance.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Limited literature is available regarding the relation between anthropometric measurements and balance in children with diabetes mellitus. Therefore, the current study will be conducted to investigate the relation between anthropometric measurements (weight, height and body mass index) and balance in children with diabetes mellitus.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Giza, Egypt, 12662
        • Amira Mahmoud Abd-elmonem

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 11 years (Child)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Children with T1DM will be selected from Abu El-Rish Hospial, Cairo University. Sample size estimation will be carried out based on a pilot study to determine the recruited number of participants. Participants will be recruited according to the following criteria.

Description

Inclusion Criteria:

  • Diagnosed as controlled T1DM.
  • Age ranges from 7 to 11 years.
  • From both sexes.
  • Duration of the disease 3 to < 5 years.
  • Same socioeconomic level.

Exclusion Criteria:

  • Other hormonal diseases (hypothyroidism or hyperthyroidism).
  • Hereditary sensory and autonomic neuropathy
  • Significant visual disorders.
  • Subjects participating in regular sports activities.
  • History of fracture or surgery in the lower extremities in the past 12 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
balance
Time Frame: baseline assessment
HUMAC balance system will be used to assess balance
baseline assessment
weight anthropometric measurement
Time Frame: baseline assessment
the anthropometric measurement will be conducted using universal weight scale
baseline assessment
height anthropometric measurement
Time Frame: baseline assessment
the anthropometric measurement will be conducted using universal height scale
baseline assessment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Investigators

  • Principal Investigator: Mohamed E Mohamed, B.S.C, Cairo university, faculty of physical therapy
  • Study Chair: Asmaa O Sayed, Phd, Cairo university, faculty of physical therapy
  • Study Director: SHaima A Mohamed, PhD, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2022

Primary Completion (Actual)

November 30, 2023

Study Completion (Actual)

November 30, 2023

Study Registration Dates

First Submitted

September 27, 2022

First Submitted That Met QC Criteria

October 10, 2022

First Posted (Actual)

October 12, 2022

Study Record Updates

Last Update Posted (Estimated)

January 31, 2024

Last Update Submitted That Met QC Criteria

January 30, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • diabetes

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 1

Clinical Trials on children with Diabetes Mellitus, Type 1

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe